CompletedNCT02734693
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Researchers compared dasotraline 4mg and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Medication studyAges 6–12United States
Understand this study
What did researchers investigate?
Researchers compared dasotraline 4mg and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
Listed age limits: 6 years to 12 years.
- Listed locations
- Newport Beach and 4 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: April 30, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 132
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT02734693
- Official title
Show the full official title
A Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of Dasotraline in Children Aged 6 to 12 Years With Attention-Deficit Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting
Get this study by email
Recruitment & locations
CompletedNewport Beach · Bradenton · Maitland
2 more locations
- Las Vegas
- Houston
Questions about this study
What did researchers investigate?
Researchers compared dasotraline 4mg and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Did this study involve medication?
Yes. The study involved medication, including dasotraline 4mg.
Who was this study for?
Listed age limits: 6 years to 12 years.
